 |
 |
|
 |
||
 |
||
|
William E. Paul, MD
Brian L. Kotzin, MD
Hugh O. McDevitt, MD
Benjamin D. Schwartz, MD, PhD
Robert S. Schwartz, MD
Lee S. Simon, MD
TASK FORCE CHAIRS Novel Research Task Force Michel Nussenzweig, MD, PhD, co-chair
New Investigators Bevra Hahn, MD, co-chair
David Wofsy, MD, co-chair
ADVISORS AT LARGE Betty Diamond, MD
Robert Eisenberg, MD
Mark Shlomchik, MD, PhD, co-chair
|
|
Dr. William Paul is the preeminent voice of immunology in America. He became Chief of the Laboratory of Immunology at the National
Institutes of Health in 1970, a position he still holds. From 1994 to 1997, Dr. Paul was Director of the Office of AIDS Research at the
NIH, where he increased the number of NIH-funded AIDS research grants by 50%. Dr. Paul is well known for his discovery of interleukin
4 (IL4), the principal regulator of allergic inflammatory diseases, and for his groundbreaking discovery in mechanisms and responses
of T and B lymphocytes. He is a member of the National Academy of Sciences, the Institute of Medicine, and a fellow of the American
Academy of Arts and Sciences, and is the recipient of numerous scientific honors.
Before his post at Amgen, Dr. Brian L. Kotzin was the Head of the Division of Clinical Immunology in the Department of Medicine,
and the Director of the Denver Autoimmunity Center of Excellence, at the University of Colorado Health Sciences Center in Denver,
Colorado. He received his medical degree from Stanford University School of Medicine in Palo Alto, California, as well as his
postdoctoral fellowship in the Division of Immunology and Rheumatology. He did his fellowship in rheumatology and medicine at
Beth Israel Hospital in Boston. Dr. Kotzin is an appointed member of the Advisory Council of the National Institute of Arthritis
and Musculoskeletal and Skin Diseases (NIAMS) at NIH. He is an associate editor for Autoimmunity, a consulting editor for the
Journal of Clinical Investigation, and serves on the editorial boards of Autoimmunity Reviews and Society for Experimental
Biology and Medicine.
Dr. McDevitt is the Burt and Marion Avery Professor of Immunology at the Department of Microbiology & Immunology at the Stanford
University School of Medicine in Palo Alto, California. He received his medical degree from Harvard University School of Medicine in
1955, and completed his internship at the Peter Bent Brigham Hospital in Boston, and his postdoctoral fellowship at Harvard Medical
School's Department of Bacteriology and Immunology. Dr. McDevitt is the recipient of numerous awards, including the American College
of Physicians Award for Research in Medical Sciences and the Outstanding Investigator Award from the National Cancer Institute of the
NIH. 
Dr. Benjamin Schwartz, a specialist in clinical research, has been Professor of Clinical Medicine, Washington University School of
Medicine since 1991, and Attending Physician at the Barnes Jewish Hospital in St. Louis since 1976. He formed the Camden Group in 1999,
where he is now CEO, to assist biotech and pharmaceutical companies in designing clinical research programs. Prior to this Dr. Schwartz
was Senior Director of Clinical Research at Searle Research and Development. He is the author of more than 150 research articles and
textbook chapters.
Dr. Robert S. Schwartz is a distinguished physician at the New England Medical Center and a Professor of Medicine at Tufts University
School of Medicine in Boston. Since 1994, he has been a deputy editor for the New England Journal of Medicine where he also serves as
the book review editor. In addition, Dr. Schwartz is a lecturer in medicine at Harvard University Medical School. He earned his medical
degree from New York University School of Medicine, and completed his residency at Montefiore Hospital and Yale New Haven Hospital.
Among his many honors, Dr. Schwartz has been awarded the Sandoz Prize For Immunology (1995), the Medawar Prize (2000), and the Thomas
Starzl Prize (2003). He serves on the editorial board of Current Opinion in Immunology and has been published in over 300 medical
journals and publications. 
In addition to his post at Harvard Medical School, Dr. Lee Simon is Head Regulatory Consultant and Scientific Advisory Board
member for MEDACorp, a consulting firm. Previously, Dr. Simon served as the Division Director of the Arthritis, Analgesic &
Ophthalmologic Drug Product Division at the FDA's Center for Drug Evaluation and Research. He received his medical degree from
the University of Maryland School of Medicine in 1976. He was a Fellow in Medicine at Johns Hopkins University School of Medicine,
and a Research Fellow in Medicine at Harvard Medical School. Dr. Simon is a Section Editor on Osteoarthritis for Current Rheumatology
Reports; and serves on the editorial boards and as a reviewer for numerous scientific publications. In received the Distinguished
Service Award from the American College of Rheumatology, the Scientific Leadership Award from the Lupus Research Institute and the
SLE Foundation, and the Quality 
Dr. Nussenzweig is the Sherman Fairchild Professor and senior physician at Rockefeller University, and a Howard Hughes Medical Institute Investigator. He is one of the nation’s most distinguished contemporary immunologists, having made extremely important contributions to the understanding of the development and function of B lymphocytes and particularly has established many of the mechanism underlying the processes through which cells capable of making auto-antibodies are normally eliminated. In addition, his studies on the biology of dendritic cells give very important insights into the mechanisms through which T cell tolerance is induced. Dr. Nussenzweig is the recipient of numerous professional honors and awards, and serves as editor of several leading professional journals including the Journal of Experimental Medicine and the Journal of Immunological Methods. The New York University School of Medicine graduate completed his clinical training at Massachusetts General Hospital and his postdoctoral training in genetics at Harvard University. 
Dr. Pisetsky is Professor of Medicine and Immunology at the Duke University Medical Center, and Chief of Rheumatology at the Durham Veterans Administration (VA) Hospital. A leading investigator in the field of autoimmunity, Dr. Pisetsky has spent years researching the pathogenesis of systemic lupus erythematosus and the immunological properties of nuclear macromolecules. He has published almost 300 papers and chapters and, in 2001, was awarded the Howley Prize from the Arthritis Foundation for his work. Dr. Pisetsky served as editor of Arthritis and Rheumatism, the leading journal in the field of rheumatology, from 200 to 2005, and currently is the physician editor of The Rheumatologist. Dr. Pisetsky received his Ph.D. and M.D. degrees from the Albert Einstein College of Medicine, and completed his internship and residency in Internal Medicine at the Yale-New Haven Hospital.
Dr. Hahn is a Professor of Medicine, Vice-Chair of the Department of Medicine, and Chief of Rheumatology at the School of
Medicine at the University of California in Los Angeles, where she has been since 1983. Dr. Hahn received her medical degree from
Johns Hopkins. She did an internship and residency in medicine at Barnes Hospital, Washington University in St. Lous. Dr. Hahn is
the past-president of the American College of Rheumatology. Among her many awards are the Dunlop-Dottridge Award of the Canadian
Rheumatism Association for research in rheumatology, and the Joseph Bunim Medal and prize of the American College of Rheumatology.
Dr. Hahn has authored more than 100 peer-reviewed research papers and over 40 book chapters or reviews as well as serving as
co-editor of an influential textbook Dubois? Lupus Erythematosus. She has served on the editorial boards of the Journal of
Clinical Investigation and the Annals of Internal Medicine. 
Dr. David Wofsy is a Professor of Medicine and Microbiology/Immunology, the Director of the Rheumatology Training Program, and the
Director of the Department of Medicine Clinical Trials Center at the University of California, San Francisco. He is also the San
Francisco Veterans Administration Medical Center's Chief of the Arthritis/Immunology Section. Dr. Wofsy received his medical degree
from University of California, San Diego Medical School in 1974. He completed a fellowship in rheumatology at the University of
California, San Francisco. Dr. Wofsy served as President of the American College of Rheumatology from 2003 to 2004. He is the 1999
recipient of the Edmund L. Dubois Memorial Award for outstanding research in the field of systemic lupus erythematosus
(presented by the American College of Rheumatology), and in 2001 received the Arthritis Foundation Hero Award.
Dr. Betty Diamond is Chief of the Autoimmune Disease Center at North Shore-LIJ Health System’s Feinstein Institute for Medical Research in Manhasset, New York. She is also a faculty member of Columbia University College of
Physician & Surgeons. Dr. Diamond received her medical degree from Harvard Medical School in 1973. She did a residency in
internal medicine at Columbia Presbyterian Medical Center, and a post-doctoral fellowship in Immunology at the Albert Einstein
College of Medicine. Dr. Diamond's research has focused on the induction and pathogenicity of anti-DNA antibodies in systemic
lupus erythematosus. She received the Outstanding Investigator Award of the American College of Rheumatology in 2001, the Lee
Howley Award from the Arthritis Foundation in 2002, and the Recognition Award from the National Association of MD-PhD Programs in 2004.
Dr. Robert Eisenberg is a Professor in the Division of Rheumatology, Department of Medicine at the University of Pennsylvania School
of Medicine in Philadelphia, Pennsylvania. From 1995 to 2004, he served as the school's Chief of the Division of Rheumatology.
Dr. Eisenberg received his medical degree from Stanford Medical School in 1971. He completed his post-doctoral fellowship with the
Scripps Clinic and Research Foundation in La Jolla, California. In 2003, Dr. Eisenberg received the Lady Barbara Colyton Award for
Autoimmunity Research from the University of Pennsylvania School of Medicine. He is a member of the American Association of
Immunologists, the American Society for Clinical Investigation, and the Philadelphia Rheumatism Society (President, 2004-2005),
among other organizations. He has previously served on the editorial boards of Infection and Immunity, the Journal of Immunology,
and Arthritis and Rheumatism.
In addition to his post at Yale University, Dr. Mark Shlomchik is the Associate Director of the Yale-New Haven Hospital Blood Bank.
Dr. Shlomchik received his MD and PhD in 1989 from the University of Pennsylvania. He completed his postdoctoral fellowship at the
Fox Chase Cancer Center and Hospital of University of Pennsylvania. Dr. Shlomchik has been published in the Journal of Immunology,
Journal of Experimental Medicine, and Current Opinion in Immunology. He is a member of the Henry Kunkel Society and the American
Society for Clinical Investigation, and was the 2005 Co-Chair of the Keystone Symposium on B Cell Development. His long-term
research interest is in the development and regulation of B lymphocytes in autoimmunity, B cell memory and transplant-related
immunopathology.
